OpenURL Connection Search

Select item for more details and to access through your institution.

Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
Published in:
Synapse, 2008, v. 62, n. 4, p. 310, doi. 10.1002/syn.20481
By:
- Lee, Joohyung;
- Gomez-Ramirez, Jordi;
- Johnston, Tom H.;
- Visanji, Naomi;
- Brotchie, Jonathan M.
Publication type:
Article
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates.
Published in:
FASEB Journal, 2012, v. 26, n. 5, p. 2154, doi. 10.1096/fj.11-195016
By:
- Johnston, Tom H.;
- Millar, Zak;
- Huot, Philippe;
- Wagg, Keith;
- Thiele, Sherri;
- Salomonczyk, Danielle;
- Yong-Kee, Christopher J.;
- Gandy, Michael N.;
- McIldowie, Matthew;
- Lewis, Katie D.;
- Gomez-Ramirez, Jordi;
- Joohyung Lee;
- Fox, Susan H.;
- Martin-Iverson, Mathew;
- Nash, Joanne E.;
- Piggott, Matthew J.;
- Brotchie, Jonathan M.
Publication type:
Article
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Published in:
Movement Disorders, 2006, v. 21, n. 11, p. 1879, doi. 10.1002/mds.21073
By:
- Visanji, Naomi P.;
- Gomez-Ramirez, Jordi;
- Johnston, Tom H.;
- Pires, Donna;
- Voon, Valerie;
- Brotchie, Jonathan M.;
- Fox, Susan H.
Publication type:
Article
Histamine H3 receptor agonists reduce.
Published in:
Movement Disorders, 2006, v. 21, n. 6, p. 839, doi. 10.1002/mds.20828
By:
- Gomez-Ramirez, Jordi;
- Johnston, Tom H.;
- Visanji, Naomi P.;
- Fox, Susan H.;
- Brotchie, Jonathan M.
Publication type:
Article
Neuropsychiatric Behaviors in the MPTP Marmoset Model of Parkinson's Disease.
Published in:
Canadian Journal of Neurological Sciences, 2010, v. 37, n. 1, p. 86, doi. 10.1017/S0317167100009707
By:
- Fox, Susan H.;
- Visanji, Naomi;
- Reyes, Gaby;
- Huot, Philippe;
- Gomez-Ramirez, Jordi;
- Johnston, Tom;
- Brotchie, Jonathan M.
Publication type:
Article

Found: 5

Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.

A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates.

Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.

Histamine H3 receptor agonists reduce.

Neuropsychiatric Behaviors in the MPTP Marmoset Model of Parkinson's Disease.